Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism
Authors
Keywords
-
Journal
GENE THERAPY
Volume 23, Issue 11, Pages 807-814
Publisher
Springer Nature
Online
2016-09-15
DOI
10.1038/gt.2016.62
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain
- (2013) W San Sebastian et al. GENE THERAPY
- Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
- (2013) S J Gray et al. GENE THERAPY
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis
- (2013) Shin H Kang et al. NATURE NEUROSCIENCE
- Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain
- (2013) Ethan G Hughes et al. NATURE NEUROSCIENCE
- Intracellular transport of recombinant adeno-associated virus vectors
- (2012) M Nonnenmacher et al. GENE THERAPY
- Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
- (2011) Steven J. Gray et al. HUMAN GENE THERAPY
- Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
- (2011) Nagesh Pulicherla et al. MOLECULAR THERAPY
- Quantitative 3D Tracing of Gene-delivery Viral Vectors in Human Cells and Animal Tissues
- (2011) Ping-Jie Xiao et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
- (2010) Piotr Hadaczek et al. MOLECULAR THERAPY
- A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
- (2010) Shin-ichi Muramatsu et al. MOLECULAR THERAPY
- Effect of Adeno-Associated Virus Serotype and Genomic Structure on Liver Transduction and Biodistribution in Mice of Both Genders
- (2009) Astrid Pañeda et al. HUMAN GENE THERAPY
- Efficient Gene Delivery and Selective Transduction of Glial Cells in the Mammalian Brain by AAV Serotypes Isolated From Nonhuman Primates
- (2009) Patricia A Lawlor et al. MOLECULAR THERAPY
- Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood–Brain Barrier (BBB)
- (2009) Steven J Gray et al. MOLECULAR THERAPY
- Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
- (2009) Aravind Asokan et al. NATURE BIOTECHNOLOGY
- Expanded Repertoire of AAV Vector Serotypes Mediate Unique Patterns of Transduction in Mouse Brain
- (2008) Cassia N Cearley et al. MOLECULAR THERAPY
- Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles
- (2008) Wuping Li et al. MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- AAV8, 9, Rh10, Rh43 Vector Gene Transfer in the Rat Brain: Effects of Serotype, Promoter and Purification Method
- (2007) Ronald L Klein et al. MOLECULAR THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started